RxDoctor Payments Data

Jeffrey Day, PA

Surgical · Smyrna, TNNPI 1558541565

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 34 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Intrinsic Therapeutics at 58.4% of the total. Reporting peaked in 2024 at $856 and has fallen 63.2% since, to $315 in 2025.

$1,444in general payments, 2019–2025

Across 34 payments — averaging $42.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intrinsic Therapeutics$843
  • Abbott$233
  • Amgen$67
  • Radius Health, Inc.$62
  • Medtronic$40
  • Si-bone, Inc.$36
  • plus $163 from 7 others
$3,000in research payments, 2019–2025

Across 10 payments — averaging $300.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Intrinsic Therapeutics$3K

What the payments were for

  • Food & beverage$1,444100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,444 in reported general payments places this provider in the 70th percentile of 206 surgical providers in Tennessee.

See all surgical providers in Tennessee

Medicare billing

Part B allowed, 2024
$38,441
Medicare patients
115
Services billed
2,287

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen269$4,140
Pregabalin151$3,030
Gabapentin274$2,481
Tramadol Hcl ErTramadol Hcl25$954
Tramadol Hcl128$650
Methylprednisolone49$360
Duloxetine Hcl35$316
Meloxicam89$298
Celecoxib11$294
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen26$277
Methocarbamol43$275
Tizanidine Hcl15$168
Cyclobenzaprine Hcl29$163
Diclofenac Sodium16$142
Oxycodone Hcl15$89

Paid to pharmacies, not to this prescriber.

Other surgical in Smyrna

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →